Charlotte Ann Rocca Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 755 Ohltown Rd, Austintown, OH 44515 Phone: 330-505-0585 |
Kimberly Dianne Zeidenstein, MHA, OTR L Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 4780 Kirk Rd, Austintown, OH 44515 Phone: 330-792-7681 |
Erin Michelle Rodgers, COTA/L Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 331 N. Yorkshire Blvd., Austintown, OH 44515 Phone: 330-707-6132 |
Kelly Elizabeth Musick Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 755 Ohltown Rd, Austintown, OH 44515 Phone: 339-505-0144 |
Jessica Ann Barth, OTR/L Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 33355 Health Campus Blvd, Avon, OH 44011 Phone: 440-937-9099 |
Alexa Mohr Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 36096 Billingsley Row, Avon, OH 44011 Phone: 440-610-6089 |
Ann Margaret Coyne, OTR/L Occupational Therapist - Physical Rehabilitation Medicare: Medicare Enrolled Practice Location: 33355 Health Campus Blvd, Avon, OH 44011 Phone: 440-937-9099 |
Heather Nicole Biltz, OTD, OTR/L Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 33355 Health Campus Blvd, Avon, OH 44011 Phone: 440-937-9099 |
Bethann Marie Popa Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 3075 Stoney Ridge Rd, Avon, OH 44011 Phone: 440-934-5124 |
Erica F Boarman, OTR/L Occupational Therapist - Pediatrics Medicare: Not Enrolled in Medicare Practice Location: 36402 N Reserve Cir, Avon, OH 44011 Phone: 440-341-3205 |
Judith Lynn Gaugler, OTR/L Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 35755 Detroit Rd, Avon, OH 44011 Phone: 440-937-6869 |
Laura J Say, O.T. Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 37701 Colorado Ave Ste D, Avon, OH 44011 Phone: 440-236-2424 Fax: 216-292-3291 |
Julia Teresa Criswell, OTR/L Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 37900 Chester Rd, Avon, OH 44011 Phone: 440-695-7100 |
Erica Danielle Furniss Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 37701 Colorado Ave Ste D, Avon, OH 44011 Phone: 216-514-1600 |
David Jason Uth, OTR/L Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 33355 Health Campus Blvd, Avon, OH 44011 Phone: 440-937-9099 |
Mrs. Rebecca Ann Young, OTR/L Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 3075 Stoney Ridge Rd, Avon, OH 44011 Phone: 440-934-5124 |
Yoo Yee Vorasane, OTR/L Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 33355 Health Campus Blvd, Avon, OH 44011 Phone: 440-937-9099 |
Jennifer Diane Reynolds Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 2538 Fairfield Dr, Avon, OH 44011 Phone: 440-503-9812 |
Katherine Kiss Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 35755 Detroit Rd, Avon, OH 44011 Phone: 440-937-3111 |
Gabrielle Valco, OTR/L Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 33355 Health Campus Blvd, Avon, OH 44011 Phone: 440-937-9099 |
News Archive
PIKAMAB, a stratified medicine biopharmaceutical company, announced today that it has secured exclusive rights to two issued U.S. patents from Hospital for Special Surgery, New York. PIKAMAB is developing Lupus TherasightTM, a novel theragnostic product that will eventually help guide the drug development process and patient treatment protocols in the areas of lupus and lupus nephritis.
Rejuvenate Bio has secured a license to commercialize a gene therapy technology developed at the Wyss Institute to treat multiple age-related diseases in dogs, which could open the door to similar treatments for humans in the future.
Oregon invites 10 firms to bid for the job of transferring Cover Oregon to the federal marketplace, and lawmakers urge marketplace officials to have backup plans in case the work is not done in time for the next open enrollment period.
Anadys Pharmaceuticals, Inc. today announced preliminary results from an ongoing Phase II study demonstrating that 73% of hepatitis C patients treated with 200 mg ANA598 twice daily in combination with pegylated interferon and ribavirin (SOC) achieved undetectable levels of virus (<15 IU/mL) at week 12, known as complete Early Virological Response or cEVR.
› Verified 9 days ago